RIVANNA® Expands World-Class Engineering Team to Advance Development of the Accuro® Product Platform CHARLOTTESVILLE, Va., Jan. 18, 2022 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the appointment of Paul Sheeran, Ph.D., as senior...

RIVANNA® Announces Partnership With BOMImed to Increase Distribution of Accuro® in Canada CHARLOTTESVILLE, Va., Dec. 01, 2021 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, announced they have entered into a partnership with BOMImed, a...

RIVANNA Purchases New Facility Signaling Rapid Growth CHARLOTTESVILLE, Va., Nov. 09, 2021 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the purchase of a 10,000 square-foot facility in...

RIVANNA's Accuro Shows Statistically Significant Efficacy and Safety for Combined Spinal-Epidural Anesthesia CHARLOTTESVILLE, Va., Sept. 27, 2021 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the results of a recent randomized controlled trial...

RIVANNA's Accuro Automatically Identifies and Measures Epidural Space Depth With Accuracy Equivalent to Standard Ultrasound in Obese Pregnant Women CHARLOTTESVILLE, Va., Sept. 13, 2021 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the results of a prospective, double-blind study...